Insider Selling: Marina Biotech Major Shareholder Unloads 100,000 Shares of Stock (MRNA)
Marina Biotech (NASDAQ:MRNA) major shareholder Cashman Llp Pryor unloaded 100,000 shares of the company’s stock in a transaction that occurred on Friday, October 4th. The shares were sold at an average price of $0.25, for a total value of $25,000.00. Following the sale, the insider now directly owns 1,700,000 shares of the company’s stock, valued at approximately $425,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Shares of Marina Biotech (NASDAQ:MRNA) traded down 0.19% during mid-day trading on Friday, hitting $0.2694. 41,175 shares of the company’s stock traded hands. Marina Biotech has a 1-year low of $0.18 and a 1-year high of $0.70. The stock has a 50-day moving average of $0.2 and a 200-day moving average of $0.26. The company’s market cap is $4.6 million.
Marina Biotech Inc, formerly MDRNA, Inc, is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (NASDAQ:MRNA).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.